Browse: Home / Sphenopalatine Ganglion Stimulation in the Pathway CH-1 Study Reduces Headache Burden Before and After Sustained Periods of Cluster Attack Remission

Menu

Skip to content
  • Home
  • About Us
  • Contact Us
  • Submit News
Header image

Cambodian TribuneLogo

Latest Cambodian News

Menu
Skip to content
  • General
  • Economy
  • Information
  • Fashion
  • Self Care
  • Athletic
  • Domestic Affairs
  • Legal
  • PRESS RELEASES
  • COVID-19: Tally Rises to 460 with Two New Cases
  • Upscale of Project on Safe Fruit and Vegetable Production Promotion
  • Minister Deeply Appreciates Cambodia’s First Virtual STEM Festival
  • Cambodia’s Luxury Products Asked to List in Thai Smile’s Onboard Food and Drink Programme
  • PM Contributes His Salary for 7 More Months to Combat COVID-19

Sphenopalatine Ganglion Stimulation in the Pathway CH-1 Study Reduces Headache Burden Before and After Sustained Periods of Cluster Attack Remission

Posted by admin on April 7, 2015 in Health Care | 26 Views

BUDAPEST, Hungary, April 8, 2015 /PRNewswire/ — During the world congress of controversies in Neurology, CONy, Autonomic Technologies[TM] presented long term data* (18 months results) on a segment of the CH-1 study patients experiencing Cluster Headache Remission periods. While Sphenopalatine Ganglion (SPG) stimulation with the Pulsante[TM] microstimulator has already shown safety and efficacy on chronic cluster headache, long-term benefits of SPG stimulation in cluster patients with remission suggest that the therapy is beneficial during the episodic phase of patients’ cluster bouts.

"This data strongly suggest that SPG stimulation could be beneficial also to episodic cluster patients", commented Prof. Miguel Lainez, Head of Neurology Department at Catholic University of Valencia and Professor of Neurology in the Catholic University of Valencia who presented the data on March 28th.

Pulsante microstimulator is the first electroceutical device that has documented efficacy in a long term RCT for the treatment of cluster headache. The Pulsante microstimulator is MR Conditional since 2012. The device is inserted through the gum with a minimally invasive technique that leaves no visible scars.

Autonomic Technologies 

Autonomic Technologies, Inc. (ATI[TM]) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company’s initial product, the Pulsante microstimulator, is CE marked in Europe for the treatment of cluster headache. The device is also under an IDE study in the US for the treatment of chronic cluster headache.  

ATI is headquartered in the San Francisco Bay Area and is backed by blue chip investors: Kleiner Perkins Caufield and Byers, InterWest Partners, Versant Ventures, Novartis Ventures, Aberdare Ventures, and the Cleveland Clinic.  http://www.pulsante.eu

Contact:
Eva Birle
+49(0)891395782711
birle@bskom.de

*Poster Presentation at 9th CONy Congress, Budapest, March 28th 2015 

Posted in Health Care | Tagged HEA, MEQ, MTC, TRI

Related Posts

Missing imageDKSH Supports Growth for Vitabiotics in Hong Kong and Malaysia→

Missing imageLatin American Contract Research Organizations Set to Get More Local Outsourcing Opportunities→

Missing imageEuropean Hospitals Will Move from Single-Use to Reusable Procedure Trays and Packs→

Missing imageJapan Helps Strengthen Community Healthcare in Kampong Cham Province→

Search

Pages

  • Home
  • About Us
  • Contact Us
  • Submit News

Categories

Calendar

January 2021
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec    

Advertisement

Latest News

  • Missing image

    COVID-19: Tally Rises to 460 with Two New Cases

    January 26, 2021 / User2
  • Missing image

    Upscale of Project on Safe Fruit and Vegetable Production Promotion

    January 26, 2021 / User2
  • Missing image

    Minister Deeply Appreciates Cambodia’s First Virtual STEM Festival

    January 26, 2021 / User2
  • Missing image

    Cambodia’s Luxury Products Asked to List in Thai Smile’s Onboard Food and Drink Programme

    January 26, 2021 / User2
  • Missing image

    PM Contributes His Salary for 7 More Months to Combat COVID-19

    January 26, 2021 / User2
  • Missing image

    Retail Pay Officially Launched

    January 26, 2021 / User2
  • Missing image

    Cambodia’s Population Reaches 15.5 Million: Latest Census

    January 26, 2021 / User2
  • Missing image

    Cambodia’s Population Increases 2.2 Million in Ten Years

    January 26, 2021 / User2
  • Missing image

    Cambodian Opposition Leader Should Push for a Speedier Trial, Analysts Say

    January 25, 2021 / User2
  • Missing image

    4.3 million square meters closer to a landmine-free Cambodia

    January 25, 2021 / User2
  • Missing image

    COVID-19: Zero New Case, but Four Recovered Patients

    January 25, 2021 / User2
  • Facebook
  • Pinterest
  • Tumblr
  • Twitter

Pages

  • About Us
  • Contact Us
  • Submit News

Categories

 

Recent Posts

  • COVID-19: Tally Rises to 460 with Two New Cases January 26, 2021
  • Upscale of Project on Safe Fruit and Vegetable Production Promotion January 26, 2021
  • Minister Deeply Appreciates Cambodia’s First Virtual STEM Festival January 26, 2021
 

Search

Archives

 

About Us

Cambodia Tribune is a website which acts as an information bank in which news and press releases from various sources are updated on a regular basis. The information is associated with Cambodia and features national news, business news, technological news and other news coverage.
 

©2021 Cambodian Tribune

Menu

  • Home
  • About Us
  • Contact Us
  • Submit News